What is IGIM?
Immune globulin for intramuscular administration (IGIM) is a sterilized solution obtained from pooled human blood. It contains the immunoglobulins (or antibodies) to protect against infectious agents that cause various diseases. Antibodies are substances in the blood that fight infections.
IGIM is used to prevent or reduce the severity of infection by hepatitis A, measles, chickenpox (varicella), and rubella. IGIM is also used to prevent or reduce the severity of other infections in individuals with immunoglobulin deficiencies.
IGIM may also be used for purposes other than those listed here.
What is the most important information I should know about IGIM?
IGIM is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although IGIM is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using IGIM.
What should I discuss with my healthcare provider before using IGIM?
Do not use IGIM without first talking to your doctor if you have
IgA deficiency;
previously had an allergic reaction to an immune globulin product;
a low level of platelets in the blood (thrombocytopenia); or
a bleeding or blood clotting disorder.
You may not be able to use IGIM, or you may require a dosage adjustment or special monitoring during treatment.
IGIM is in the FDA pregnancy category C. This means that it is not known whether it will be harmful to an unborn baby. Do not use IGIM without first talking to your doctor if you are pregnant or could become pregnant during treatment.
It is not known whether IGIM passes into breast milk. Do not use IGIM without first talking to your doctor if you are breast-feeding a baby.